Clinical Trials Directory

Trials / Sponsors / Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

Industry · 14 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationOpen-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Phase 22025-12-28
RecruitingA Phase 1 Study of WVE-007 in Adults Living With Overweight or Obesity
Obesity and Overweight
Phase 12025-01-31
Active Not RecruitingA Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ
Alpha-1 Antitrypsin Deficiency
Phase 1 / Phase 22024-07-19
CompletedA Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Particip
Alpha-1 Antitrypsin Deficiency (AATD)
Phase 12023-11-14
TerminatedOpen-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis
ALS, FTD
Phase 1 / Phase 22022-12-14
RecruitingOpen-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Duchenne Muscular Dystrophy
Phase 1 / Phase 22021-09-28
CompletedStudy of WVE-003 in Patients With Huntington's Disease
Huntington Disease
Phase 1 / Phase 22021-09-06
TerminatedStudy of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dem
ALS, FTD
Phase 1 / Phase 22021-06-28
TerminatedOpen-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's
Huntington Disease
Phase 1 / Phase 22020-04-13
TerminatedOpen-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's
Huntington Disease
Phase 1 / Phase 22019-09-24
TerminatedEfficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duc
Duchenne Muscular Dystrophy
Phase 2 / Phase 32019-09-04
CompletedSafety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Phase 12018-01-24
TerminatedSafety and Tolerability of WVE-120101 in Patients With Huntington's Disease
Huntington's Disease
Phase 1 / Phase 22017-07-17
TerminatedSafety and Tolerability of WVE-120102 in Patients With Huntington's Disease
Huntington's Disease
Phase 1 / Phase 22017-07-17